Texas Tech University Health Sciences Center
Texas Tech University Health Sciences Center
Explore linked clinical trials.18 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sepsis Biomarker Monitoring in Burn Patients | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, burn, injury | Not yet recruiting | Not applicable | 2026-10-08 | NCT07866521 | |
| Tocotrienols for Obesity of Postmenopausal Women | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT03705845 | |
| Annatto-derived GG for Statin-associated Myopathy | muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease | Recruiting | Phase 1 / Phase 2 | 2026-09-11 | NCT05312424 | |
| Effect of Ultrasound-Guided Dry Needling Targeting Rectus Capitus Posterior Major on Individuals With Headaches | Cervicogenic Headache, Headache, Headache Disorders, Secondary, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Post-Traumatic Headache, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, nervous system disorder | Recruiting | Not applicable | 2026-09-09 | NCT07309874 | |
| Snacks and Brain Health | Inflammation, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-08 | NCT07348406 | |
| EEG-Guided Binaural Beat Audio to Reduce Performance-Related Stress and Improve Cognition | Cognitive Abilities; Cognitive Performance; Performance; Stress | Recruiting | Not applicable | 2026-08-24 | NCT07407426 | |
| Fitbit-Tracked Micromovement for Cardiometabolic Health in Rural Women | Insulin Resistance, Nutritional and Metabolic Diseases, glucose metabolism disease, hyperinsulinism, metabolic disease | Not yet recruiting | Not applicable | 2026-07-15 | NCT07704749 | |
| Zynrelef vs Exparel: The Battle of Postoperative Pain Control After Robotic Sleeve Gastrectomy | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms | Recruiting | Early phase 1 | 2026-07-08 | NCT06349772 | |
| Stroboscopic Vision Training in Softball | Sports Performance; Vision, Ocular | Active, not recruiting | Not applicable | 2026-06-29 | NCT04309188 | |
| Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Recruiting | Phase 1 / Phase 2 | 2026-06-29 | NCT03934905 | |
| Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients | Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, Stress Disorders, Traumatic, acute stress disorder, depressive disorder, post-traumatic stress disorder, psychiatric disorder | Recruiting | Phase 4 | 2026-03-24 | NCT06903819 | |
| Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction | Ankle Reconstruction; Blood Flow Restriction Therapy; Physical Therapy | Recruiting | Not applicable | 2026-03-17 | NCT07451210 | |
| Repurposing Siponimod for Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-03-04 | NCT06639282 | |
| Speech Intervention Via Telepractice for Children With Repaired Cleft Palate | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Craniofacial Abnormalities, Jaw Abnormalities, Jaw Diseases, Maxillofacial Abnormalities, Mouth Abnormalities, Musculoskeletal Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Speech Sound Disorder, Stomatognathic Diseases, Stomatognathic System Abnormalities, cleft palate, communication disorder, mouth disorder, musculoskeletal system disorder, nervous system disorder, neurodevelopmental disorder, psychiatric disorder | Not yet recruiting | Not applicable | 2026-02-27 | NCT07434375 | |
| Curcumin and Retinal Study | Bioavailability; Gut Microbiome; Safety | Recruiting | Phase 1 / Phase 2 | 2026-01-13 | NCT05774704 | |
| Prospective Data Bank Creation to Study Vaginal Conditions | Bacterial Infections and Mycoses, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Obstetric Labor Complications, Obstetric Labor, Premature, Urogenital Diseases, bacterial infectious disease, bacterial vaginosis, female reproductive system disorder, fungal infectious disease, pregnancy disorder, vaginal disorder, vaginitis, vulvar disease, vulvodynia | Recruiting | Not stated | 2025-12-18 | NCT01829204 | |
| Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-09 | NCT05806385 | |
| Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Phase 3 | 2025-05-01 | NCT06303128 |